Last reviewed · How we verify
Inactive tuberculosis
Approved treatments
- Rifadin · Sanofi Aventis Us
- Isoniazid · Epic Pharma Llc
Isoniazid works by inhibiting the enzyme myeloperoxidase, which is essential for the survival of Mycobacterium tuberculosis. - isoniazide · Bridge BioResearch Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Inactive tuberculosis patent landscape — cliff calendar, originator estates, attackable patents
- Inactive tuberculosis treatment landscape brief
- Inactive tuberculosis treatment updates RSS
Frequently asked questions about Inactive tuberculosis
What drugs treat Inactive tuberculosis?
Tracked treatments include Rifadin, Isoniazid, isoniazide.
What is the treatment for Inactive tuberculosis?
Standard treatment for Inactive tuberculosis includes Rifadin, Isoniazid, isoniazide. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Inactive tuberculosis patent cliff · Inactive tuberculosis CI report
- Treatment: Rifadin · Sanofi Aventis Us
- Treatment: Isoniazid · Epic Pharma Llc
- Treatment: isoniazide · Bridge BioResearch Ltd.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing